Company Overview of Anosys Inc.
As of December 31, 2005, Anosys Inc. was acquired by Chromos Molecular Systems Inc. Anosys Inc. develops therapeutic vaccines for the treatment of cancer, infectious, and autoimmune diseases. Its products are based on exosomes, which are small vesicles that contain components required to activate the innate and cellular immune responses necessary to fight disease. The company is based in Menlo Park, California and has an additional office in Evry, France.
1014 Hamilton Court
Menlo Park, CA 94025
Key Executives for Anosys Inc.
Anosys Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Anosys Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.